메뉴 건너뛰기




Volumn 9, Issue 17, 1998, Pages 3869-3873

COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA

Author keywords

AMPA receptor; COX 1; COX 2; Hyper algesia; NMDA receptor

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; DIMETHYL SULFOXIDE; DRUG VEHICLE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

EID: 0032444328     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812010-00019     Document Type: Article
Times cited : (39)

References (16)
  • 16
    • 0005279280 scopus 로고    scopus 로고
    • Modulation of NMDA receptor function for pain treatment
    • Yaksh TL, Maze M, Lynch C III et al. eds. Anesthesia: Philadelphia: Lippincott Raven Publishers
    • Kristensen JD and Gordh T. Modulation of NMDA receptor function for pain treatment. In: Yaksh TL, Maze M, Lynch C III et al. eds. Anesthesia: Biologic Foundations. Philadelphia: Lippincott Raven Publishers, 1998: 943-952.
    • (1998) Biologic Foundations , pp. 943-952
    • Kristensen, J.D.1    Gordh, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.